Openbookopenbook
Equity
CLX
+0.0 · +0.00%
USD · NYSE

The Clorox Company(CLX) Stock Analysis | Consumer Defensive

USD --+0.00%
Reward41Moderate
Risk44Moderate
75%Data
4.7% dividend yield
Dividend King
Market Cap:12.90Bn
ⓘ
Reward Rating
41
Moderate
Reward Assessment
75% data coverage
Bottom 10% of stocksView factors
ⓘ
Risk Rating
44
Moderate
Risk Assessment
5 metrics flaggedView details

Educational tool only – Scores are based on historical data and financial metrics for informational purposes. This is not financial advice or a recommendation to buy or sell any security. Always conduct your own research or consult a qualified financial adviser.

Educational tool only · More
Limited data coverage
We don't have enough public data on CLX to score it reliably yet — Reward, Risk, Forecasts and Dividends tabs aren't available for this stock. The price chart and basic profile are still shown.
OTC / ADR stock — scores and fundamentals use data tagged in USD by our provider. The issuer may report in a different home currency (e.g. JPY), so treat figures as directional rather than precise.
New listing — limited trading history
Fundamental and analyst data are available for CLX, but momentum and volatility metrics will develop as more trading history accumulates (0 trading sessions so far).
Not available yet for this stock
The overview tab requires data we don't have for this stock yet. The price chart is the most reliable view we have — try the Chart tab.
Earnings Ex-dividend

Market Performance

Stock returned +10.0% over the past year, broadly in line with market conditions.

Analyst Target

Analyst consensus price target: $101.65.

What is The Clorox Company?

The Clorox Company manufactures and markets consumer and professional products worldwide.

CLX · Verdict

Moderate reward · moderate risk

CLX stands out on volatility and cash flow, but watch the balance sheet signal.

Based on 88% data coverage

CLX · Verdict

What’s working & what to watch

Strengths 2

  • Volatility80/100

    Top decile vs peers

  • Cash flow69/100

    6% free-cash-flow margin

Watchouts 3

  • Balance sheet7/100

    Net debt/EBITDA 5.8×

  • Valuation17/100

    P/E 18.3× · PEG 1.34

  • Growth42/100

    Rev -3.1% CAGR · earnings +57.9%

Model-based scoring. For information only — not financial advice.

What is The Clorox Company?

The Clorox Company manufactures and markets consumer and professional products worldwide. The company operates through four segments: Health and Wellness, Household, Lifestyle, and International. The company is listed on the NYSE in USA, operating in the Consumer Defensive sector, with a market capitalisation of 12.90B, and a P/E ratio of 22.0x.

Financial Highlights

Investment Breakdown

Growth
Growth trend is developing — watch for revenue consistency over upcoming quarters.
Profitability
Profitability metrics are mixed — margins may be under pressure.
Risk
Risk profile appears balanced versus broad market conditions.
Valuation
Premium valuation reflects strong growth expectations already priced in.

OpenBook Logo Analysis

Reward: Moderate (41)

The scoring profile indicates limited reward potential at this time, with momentum and size offering the most support. Risk indicators are moderate, consistent with typical market exposure.

For informational purposes only. Not financial advice.

Similar stocks to compare

A short list of Household & Personal Products names that are close enough in size to make side-by-side comparison useful.

UNICYLarge Cap / 12.4B market cap
Unicharm Corp
Compare
PUGBYLarge Cap / 14.8B market cap
Puig Brands SA
Compare
PUIGFLarge Cap / 16.9B market cap
PUIGF
Compare
Company Information
SectorConsumer Defensive
IndustryHousehold & Personal Products
Market Cap12.90B
P/E Ratio22.0434
Dividend Yield4.69%
Beta0.541
Insider Activity
12M windowQuiet
Fewer than three real open-market insider trades in the last 12 months. Mechanical activity (option exercises, RSU vests) is excluded from the signal.
9 disclosures without share count
openbook

Stock research for UK and US investors. Make smarter decisions, faster.

Questions? Email us at contact@openbookanalytics.com

© 2026 Openbook Analytics Ltd · Company No. SC843579 · Registered in Scotland

256-bit encryption GDPR compliant UK data centres

Openbook Analytics Ltd (Company No. SC843579) is registered in Scotland. Registered office: Strathclyde Inspire Hub, University of Strathclyde, Graham Hills Building (Level 6), 50 Richmond Street, Glasgow, G1 1XP. Openbook Analytics is not authorised or regulated by the Financial Conduct Authority (FCA). The content on this platform is provided for general informational and educational purposes only and does not constitute financial advice, investment advice, trading advice, or any other form of advice. You should not treat any content on this platform as a recommendation to buy, sell, or hold any financial instrument. Past performance is not a reliable indicator of future results. The value of investments and the income from them can go down as well as up, and you may get back less than you invest. User-generated content, including community posts and commentary, reflects the personal opinions of individual users, is not verified for accuracy, and does not represent the views of Openbook Analytics Ltd. You should always conduct your own research or consult a qualified, FCA-regulated financial adviser before making investment decisions. Data displayed on this platform may be delayed or inaccurate and is provided "as is" without warranty. Openbook Analytics Ltd accepts no liability for any loss arising from reliance on the information provided.